Boeing Deal, Microsoft Layoffs, US Drug Prices & AI Competition | Bloomberg Intelligence

Supreme Court and Presidential Authority

• ⚖️ Research suggests the Supreme Court would likely allow President Trump to fire Fed Chair Powell, even if markets react negatively.
• 🏛️ This is viewed as part of Trump's expansive view of executive authority, challenging for-cause removal restrictions on independent agencies.
• 🏛️ Litigation is ongoing for firings at the FTC and NLRB, with judges ruling along ideological lines.
• 🏛️ The Supreme Court's handling of the TikTok ban, where the president's attorney general was instructed to ignore the ruling, sets a precedent for potential defiance.

Boeing's Aerospace Resurgence

• ✈️ China has lifted a ban on Boeing deliveries, allowing for the immediate shipment of approximately 50 Boeing jets.
• ✈️ This move is a positive for Boeing, helping to clear inventory and focus on new production.
• ✈️ A significant $96 billion deal with Qatar Airways for up to 210 widebody aircraft, including the 787 Dreamliner and 777X, marks Boeing's largest-ever order.
• 🏭 Boeing is improving quality and throughput, with a projected 45-50% increase in 737 deliveries this year, driving cash flow.
• 🌍 The aviation industry faces ongoing supply chain issues and labor shortages, impacting delivery timelines for both Boeing and Airbus.

Microsoft's Strategic Adjustments

• ✂️ Microsoft announced job cuts affecting 6,000 employees, primarily to reduce management layers and improve efficiency.
• 💡 This move is partly driven by increased productivity from AI in areas like coding and R&D, reducing the need for headcount growth.
• 💰 Microsoft is making significant investments in AI (over $80 billion in capex), necessitating cuts in operating expenses to protect profit margins.
• ☁️ Microsoft is well-positioned in AI due to hosting ChatGPT, benefiting from its growing user base and inferencing services.

US Drug Pricing and Pharmaceutical Landscape

• 💊 President Trump's executive order aims to lower US drug prices, encouraging voluntary reductions from manufacturers.
• 🇪🇺 Unlike the US, European countries have single-payer systems (governments) that negotiate lower drug prices.
• 💡 The effectiveness of the US order is debated, with concerns that forcing lower prices globally could stifle innovation and R&D investment.
• 💰 Pharmacy Benefit Managers (PBMs) are identified as a key area of risk, with questions raised about their role and necessity in the supply chain.

DeepSeek and the AI Competition

• 🇨🇳 Chinese AI startup DeepSeek gained attention for training advanced models (R1, V3) with fewer cutting-edge Nvidia chips and at a lower cost.
• 💡 DeepSeek utilizes techniques like